General Information of Drug (ID: DMQZCL5)

Drug Name
FID-007
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
DE7Q3R

References

1 ClinicalTrials.gov (NCT03537690) A Phase I Study of FID-007 in Patients With Advanced Solid Tumors. U.S.National Institutes of Health.